Evidence map›Paper›PMID 42505461›Full record

ArticleBiosensors2026

Universal, Rapid, and Cleavable Labeling of Antibodies by Fluorophores and DNA Oligonucleotides for Multiplex Immunostaining and Spatial Proteomics Through MIST Linker.

Arafat Meah, Shuo Yin, Saimoen Strrrz Anderson, Ming Lin, Shuo Liang, Meghana Davuluri, Yi-Xian Qin, Sandeep K Mallipattu, Jun Wang

Abstract read
In one paragraph

Article in Biosensors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Arafat MeahMultiplex Biotechnology Laboratory, Department of Biomedical Engineering, State University of New York at Stony Brook, Stony Brook, NY 11794, USA.ORCID 0009-0009-4908-6523
Shuo YinMultiplex Biotechnology Laboratory, Department of Biomedical Engineering, State University of New York at Stony Brook, Stony Brook, NY 11794, USA.ORCID 0000-0003-4273-7839
Saimoen Strrrz AndersonMultiplex Biotechnology Laboratory, Department of Biomedical Engineering, State University of New York at Stony Brook, Stony Brook, NY 11794, USA.
Ming LinDepartment of Computer Science, State University of New York at Stony Brook, Stony Brook, NY 11794, USA.ORCID 0009-0008-3481-7066
Shuo LiangMultiplex Biotechnology Laboratory, Department of Biomedical Engineering, State University of New York at Stony Brook, Stony Brook, NY 11794, USA.
Meghana DavuluriDepartment of Biomedical Engineering, State University of New York at Stony Brook, Stony Brook, NY 11794, USA.
Yi-Xian QinDepartment of Biomedical Engineering, State University of New York at Stony Brook, Stony Brook, NY 11794, USA.
Sandeep K MallipattuDivision of Nephrology and Hypertension, Department of Medicine, Stony Brook School of Medicine, Stony Brook, NY 11794, USA.
Jun WangMultiplex Biotechnology Laboratory, Department of Biomedical Engineering, State University of New York at Stony Brook, Stony Brook, NY 11794, USA.

Funding

Transcriptional control of mitochondrial function by KLF6 in diabetic kidney diseaseR01DK112984 · NIDDK · STATE UNIVERSITY NEW YORK STONY BROOK · PI Sandeep K Mallipattu · 2017 to 2026
$3.5M
Mechanisms mediating podocyte-parietal epithelial cell crosstalk in proliferative glomerulopathiesR01DK121846 · NIDDK · STATE UNIVERSITY NEW YORK STONY BROOK · PI HE, JOHN CIJIANG, MALLIPATTU, SANDEEP K · 2020 to 2024
$2.7M
Advanced Single-Cell Protein Analysis with Multiplex in Situ Tagging Array TechnologyR35GM151972 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI Jun Wang · 2024 to 2026
$1.2M
Regulatory Landscape of Neurodegeneration by Single-Cell Spatial MultiomicsR21AG092994 · NIA · STATE UNIVERSITY NEW YORK STONY BROOK · PI Sai Ma, Jun Wang · 2026 to 2026
$455k
Single-cell Cyclic Multiplex in Situ Tagging to Advance Kidney ResearchR21DK138409 · NIDDK · STATE UNIVERSITY NEW YORK STONY BROOK · PI MALLIPATTU, SANDEEP K, WANG, JUN · 2023 to 2023
$337k
BLRD VA I01 BX003698BLRD VA I01 BX005300Dialysis Clinic N/pNIA NIH HHS AG092994NIA NIH HHS R21 AG092994NIDDK NIH HHS DK112984NIDDK NIH HHS DK121846NIDDK NIH HHS DK138409NIDDK NIH HHS R01 DK112984NIDDK NIH HHS R01 DK121846NIDDK NIH HHS R21 DK138409NIGMS NIH HHS GM151972NIGMS NIH HHS R35 GM151972Stony Brook University OVPR Seed GrantStony Brook University Pilot awardStony Brook University TRO VDR awardUnited States Department of Veterans Affairs I01BX003698; 1I01BX005300U.S. National Science Foundation 2327144
6 · The paper itself

Abstract

Direct antibody labeling is essential for immunoassays, multiplexed imaging, and biosensing; however, current methods are often time-consuming, restricted by antibody source, risk compromising protein performance, or vary with multiple steps. We introduce multiplex in situ tagging (MIST) Linker, a rapid and Fc-site-specific labeling tool that conjugates fluorophores or DNA oligonucleotides to antibodies from diverse commercial sources in as fast as 10 min using minimal starting material. MIST Linker achieves >90% cleavage upon UV exposure, facilitating rapid cyclic imaging on a single specimen. Validated across multiple species and sources, the platform outperforms conventional two-step immunofluorescence and immunohistochemistry in various tissues and cell lines. By enabling the rapid, cost-effective customization of antibody panels, MIST Linker significantly lowers the barrier to accessing antibody-DNA conjugates for spatial biology. When integrated with the spatial MIST platform and MIST-Explorer, it enables high-plex, single-cell spatial proteomics at high signal-to-noise ratios in human clinical biopsies, mouse specimens and cell lines. This toolkit provides an efficient, accessible solution for high-resolution spatial mapping, allowing for the in-depth analysis of cell subpopulations, biomarker distributions, and signaling events in complex biological specimens. Thus, MIST Linker offers a versatile, accessible, and scalable solution for antibody-labeling-based research and clinical diagnosis.

Indexed as

AntibodiesFluorescent DyesOligonucleotidesProteomicsAnimalsBiosensing TechniquesDNAHumansImmunohistochemistryMiceStaining and LabelingAntibodiesDNAFluorescent DyesOligonucleotidesantibody labelingMIST Linkernanobody labelingphotocleavable linkersingle cell analysisspatial proteomics

Identifiers

PMID42505461
PMCPMC13407159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.